Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,423 | 860 | 98.6% |
| Education | $181.43 | 13 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,611 | 97 | $0 (2024) |
| Lilly USA, LLC | $1,291 | 101 | $0 (2024) |
| Novo Nordisk Inc | $1,245 | 86 | $0 (2024) |
| GlaxoSmithKline, LLC. | $927.36 | 65 | $0 (2024) |
| PFIZER INC. | $883.02 | 69 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $765.42 | 52 | $0 (2023) |
| Merck Sharp & Dohme LLC | $617.55 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $603.82 | 46 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $507.71 | 36 | $0 (2022) |
| Amgen Inc. | $482.59 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,114 | 65 | AstraZeneca Pharmaceuticals LP ($191.13) |
| 2023 | $1,533 | 107 | Lilly USA, LLC ($253.26) |
| 2022 | $1,430 | 90 | Lilly USA, LLC ($201.20) |
| 2021 | $1,695 | 112 | AstraZeneca Pharmaceuticals LP ($241.51) |
| 2020 | $1,185 | 76 | AstraZeneca Pharmaceuticals LP ($231.06) |
| 2019 | $1,443 | 108 | Novo Nordisk Inc ($289.12) |
| 2018 | $1,844 | 135 | AstraZeneca Pharmaceuticals LP ($317.43) |
| 2017 | $2,360 | 180 | Novo Nordisk Inc ($369.65) |
All Payment Transactions
873 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 12/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Narcoplepsy | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VACCINE | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardio-renal | ||||||
| 07/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: VACCINES | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,169 | 4,157 | $477,473 | $175,586 |
| 2022 | 21 | 2,122 | 3,707 | $459,630 | $166,364 |
| 2021 | 22 | 1,994 | 3,725 | $417,708 | $154,040 |
| 2020 | 24 | 2,144 | 3,910 | $401,533 | $131,024 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 637 | 1,349 | $283,300 | $95,680 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 385 | 689 | $103,350 | $35,422 | 34.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 199 | 200 | $15,000 | $14,225 | 94.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $12,375 | $9,321 | 75.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 201 | 202 | $6,060 | $5,736 | 94.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $9,180 | $2,539 | 27.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 68 | 71 | $8,520 | $2,430 | 28.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 67 | 140 | $4,900 | $2,241 | 45.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 35 | $5,436 | $1,723 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 115 | 185 | $6,845 | $1,702 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,353 | $1,453 | 33.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 33 | 33 | $1,617 | $946.44 | 58.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 73 | 98 | $2,450 | $804.93 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 54 | $1,350 | $438.55 | 32.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 16 | $1,267 | $362.64 | 28.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 77 | 412 | $8,240 | $285.66 | 3.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 70 | 90 | $2,160 | $198.00 | 9.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 24 | 116 | $174.00 | $36.72 | 21.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 65 | 320 | $320.00 | $24.14 | 7.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 48 | $576.00 | $17.40 | 3.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 576 | 1,174 | $246,540 | $85,798 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 418 | 740 | $111,000 | $35,120 | 31.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 198 | 198 | $14,850 | $13,568 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 201 | 203 | $6,090 | $5,512 | 90.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $16,484 | $5,252 | 31.9% |
About Dr. Francois Dutoit, MD
Dr. Francois Dutoit, MD is a Family Medicine healthcare provider based in Lawton, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760477509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francois Dutoit, MD has received a total of $12,604 in payments from pharmaceutical and medical device companies, with $1,114 received in 2024. These payments were reported across 873 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,423).
As a Medicare-enrolled provider, Dutoit has provided services to 8,429 Medicare beneficiaries, totaling 15,499 services with total Medicare billing of $627,015. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Lawton, OK
- Active Since 09/19/2005
- Last Updated 04/03/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760477509
Products in Payments
- FARXIGA (Drug) $854.60
- JARDIANCE (Drug) $705.36
- TRULICITY (Drug) $554.78
- Victoza (Drug) $462.77
- Ozempic (Drug) $437.29
- JANUVIA (Drug) $406.70
- ANORO (Drug) $328.16
- VRAYLAR (Drug) $317.30
- TRELEGY ELLIPTA (Drug) $316.62
- SOLIQUA 100/33 (Biological) $313.28
- XARELTO (Drug) $296.57
- NUEDEXTA (Drug) $270.23
- INJECTAFER (Drug) $266.98
- MOUNJARO (Drug) $245.47
- SYMBICORT (Drug) $241.88
- ELIQUIS (Drug) $236.59
- TOUJEO (Drug) $224.69
- ENTRESTO (Drug) $212.52
- INVOKANA (Drug) $211.14
- CHANTIX (Drug) $203.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lawton
Dr. Aryan Kadivar, M.d, M.D
Family Medicine — Payments: $12,663
Monica Reicks, Md, MD
Family Medicine — Payments: $8,900
Jaroslaw Paszkowiak, Md, MD
Family Medicine — Payments: $7,043
Ivanka Vassileva, Md, MD
Family Medicine — Payments: $6,244
Richard Campbell, M.d, M.D
Family Medicine — Payments: $5,270
Gretchen Stroud, D.o, D.O
Family Medicine — Payments: $5,053